Callodine Capital Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-35,433
Closed -$328K 46
2023
Q2
$328K Sell
35,433
-198,842
-85% -$1.68M 0.09% 36
2023
Q1
$1.93M Sell
234,275
-825,725
-78% -$9.12M 0.57% 34
2022
Q4
$11.8M Buy
1,060,000
+175,000
+20% +$2.03M 3.52% 11
2022
Q3
$10.5M Buy
885,000
+256,794
+41% +$3.89M 3.26% 14
2022
Q2
$9.59M Buy
628,206
+73,206
+13% +$1.32M 2.84% 16
2022
Q1
$11.7M Buy
555,000
+190,000
+52% +$4.09M 3.77% 8
2021
Q4
$8.63M Buy
365,000
+40,000
+12% +$857K 3.34% 13
2021
Q3
$6.52M Buy
325,000
+160,000
+97% +$3.28M 2.46% 16
2021
Q2
$3.32M Buy
+165,000
New +$3.53M 1.25% 29

Other funds holding MPT

Callodine Capital Management's MPT Position: Q3 2023 in Review

Callodine Capital Management sold out of Medical Properties Trust (MPT) in Q3 2023, closing a stake of 35,433 shares — an estimated $328K sold.

Callodine Capital Management first reported a position in MPT in Q2 2021 and held it in 9 quarters. The position peaked at $11.8M in Q4 2022. 541 funds tracked by Wall St. Rank hold MPT as of Q3 2023.

  • Callodine Capital Management reported no remaining Medical Properties Trust position as of Q3 2023 after selling out during the quarter.
  • Callodine Capital Management sold 35,433 Medical Properties Trust shares in Q3 2023, an estimated $328K.
  • Callodine Capital Management first reported a position in Medical Properties Trust in Q2 2021 and held it in 9 quarters.
  • Callodine Capital Management's Medical Properties Trust position peaked at $11.8M in Q4 2022.
  • 541 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2023.

Based on Callodine Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.